DxScript vs DoseSpot ePrescribing

DxScript® ePrescribing service puts eligibility, benefits, and formulary information at your fingertips at the time of prescribing. This enable prescriber to select medications that are on formulary and are covered by the patient's drug benefit. It also informs you of lower cost alternatives such as generic drugs. Prescriber can access a timely and clinically sound view of a patient's prescription history across providers, at the point of care. This decreases the risk of preventable medication errors. DxScript® replaces old, error-phone approach to writing. Printing new prescription electronically in your office reduces the risk of medication errors associated with poor handwriting, illegible faxes and manual data entry. Using DxScript® to process prescription renewals saves you time and money by dramatically reducing the number  of phone calls and faxes typically associated with the prescription renewal authorization process.

DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable, and integratable e-Prescribing solutions to healthcare IT companies since 2009. We’ve helped more than 220 medical, dental, hospice, and digital health organizations seamlessly integrate e-prescribing into the workflow they are already using. The trust our clients place in us has made us the fastest growing eprescribing company in the United states. We are Surescripts meaningful use, and ePCS certified and can handle the medication-related criteria for ONC Meaningful Use Certification for Electronic Health Records. Write and send electronic prescriptions (controlled substances, non-controlled substances, supplies, and compounds). Access patient history, medication risks (including side affects), drug-drug and drug-allergy interactions, formulary information, Narx scores, and more.